GENEWIZ, from Azenta Life Sciences, is a global leader in multiomics and synthetic biology services. GENEWIZ empowers our customers research by providing high-quality solutions from discovery through clinical development, enabling scientists to make breakthroughs faster and more efficiently.
Key services include Next Generation and Sanger sequencing, gene synthesis, gene-to-discovery solutions including antibody production, viral packaging, and mRNA synthesis.
GENEWIZ, part of Azenta Life Sciences, delivers NGS solutions from sample preparation to bioinformatics. Using leading platforms and expert scientific support, we provide reliable, publication-ready data for research, biotech and pharma projects
GENEWIZ Proteomics services leverage Olink® and Alamar NULISA™ technologies to enable biomarker discovery, disease understanding, and therapeutic target identification through high-quality, scalable protein analysis.
GENEWIZ Gene Synthesis delivers custom genes, DNA fragments, oligos, libraries, and CRISPR constructs with fast turnaround and expert support, helping accelerate research, protein expression, cell engineering, and therapeutic development.
GENEWIZ Sanger Sequencing delivers fast, reliable, and cost-effective DNA sequencing with high-quality results and expert support. From single samples to high-throughput projects, we help researchers accelerate discoveries